Five breakthrough moments from AAIC 2025 that are reshaping Alzheimer's research

Incorporating the patient voice to improve ulcerative colitis recruitment

Non-invasive biomarkers: Promising future to reduce patients’ burden and accelerate drug development in MASH

Can innovation in clinical trial delivery meet the demands of increasing complexity in drug development?

Discover how innovation in complex clinical trial design can address growing clinical trial complexity and improve productivity in drug development.

Regulatory intelligence in action: Transforming compliance into strategy

Dr Marcus Stavchansky, PharmD

Dr Marcus Stavchansky PharmD, Executive Director, Global Head Pharmacy Services. Dr Stavchansky is Executive Director and Global Head of Pharmacy Services at Fortrea, based in Dallas, Texas.

In-clinic cGMP Pharmacies

Accelerate Phase 1 clinical trials with Fortrea’s on-site cGMP pharmacies. Small-batch drug manufacturing ensures quality, safety, and cost savings.

Project Optimus: The evolution of dose optimisation in oncology

Leveraging community-based clinical trial sites to expand oncology research access

This article reviews the concept of a commuity site and explores the current barriers limiting involvement of community sites in clinical trials.